Comment to “Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation” Haematologica. 2012;97(12):1845-9.

• Andreas Holbro,
• Martine Jotterand,
• Jakob R Passweg,
• Andreas Buser,
• André Tichelli,
• Alicia Rovó

Affiliations

Andreas Holbro

Division of Hematology, University Hospital Basel;Blood Transfusion Centre, Swiss Red Cross, Basel

Martine Jotterand

Service de Génétique Médicale, University of Lausanne, Switzerland

Jakob R Passweg

Division of Hematology, University Hospital Basel

Andreas Buser

Division of Hematology, University Hospital Basel;Blood Transfusion Centre, Swiss Red Cross, Basel

André Tichelli

Division of Hematology, University Hospital Basel

Alicia Rovó

Division of Hematology, University Hospital Basel